Akorn Inc. (AKRX) News, Price and Chart - FAWS

Your browser has either disabled or does not support javascript. Javascript is required for full website experience.

Fri February 26th, 2021

- 21:49
  Press ReleasesAkorn Announces Review of Strategic Alternatives for the Akorn Consumer Health BusinessPR Newswire

Thu February 11th, 2021

- 14:10
  Press ReleasesAkorn Receives FDA Approval for Loteprednol Etabonate Ophthalmic Gel, 0.5%PR Newswire

Wed October 28th, 2020

- 21:49
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  90
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  Press ReleasesAkorn Announces Its New Board of DirectorsPR Newswire

Fri October 2nd, 2020

- 01:11
  Press ReleasesAkorn Successfully Completes Sale to Lenders and Exits Chapter 11 ProtectionPR Newswire

Wed May 27th, 2020

- 21:25
  Akorn Files For Bankruptcy Protection - Existing Equity Holders Will Almost Certainly Be Wiped OutSeeking Alpha

SPY$395.63-3.9%

QQQ$315.85-6.3%

DOW$64.141.6%

X.BTC$60,045.86-0.018%

GME$178.513%

NDAQ$149.79-4%

TSLA$621.3-8.2%

SPY$395.63-3.9%

QQQ$315.85-6.3%

DOW$64.141.6%

X.BTC$60,045.86-0.018%

GME$178.513%

NDAQ$149.79-4%

TSLA$621.3-8.2%

About Developer Contact